Reproductive Medicine Report: IVF, FSH Levels, and Frozen Blastocysts

This report delves into the realm of sexual and reproductive medicine, focusing on a case study involving a woman named Phillipa facing fertility issues. The report examines the process of in-vitro fertilization (IVF), including the use of sperm from a known donor and the legal implications of parental responsibility within the context of the National Health Service (NHS) in the UK. It explores the role of Follicle Stimulating Hormone (FSH) in the context of Phillipa's sporadic periods and elevated FSH levels, discussing potential diagnoses such as primary ovarian insufficiency and polycystic ovary syndrome. Additionally, the report discusses the treatment of frozen blastocysts and how the treatment would continue if Phillipa proceeds with an amicable arrangement, highlighting the importance of a comprehensive understanding of reproductive health for effective treatment. This report aims to provide a detailed overview of reproductive medicine, offering insights into IVF cycles, hormonal influences, and treatment options.

Sexual and
reproductive medicine

Table of Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY...................................................................................................................................1
11. By using of Sperm from 'known donar' in an IVF cycle at National Health Service fertility
clinic in UK. ...............................................................................................................................1
22. Explain Follicle stimulating hormone in context of phillipa pregnancy case.......................2
33. Discuss the treatment of frozen blastocysts. How would treatment continue if Phillipa
continues towards amicable arrangement? ...............................................................................2
CONCLUSION................................................................................................................................2
REFERENCES ...............................................................................................................................3

INTRODUCTION
Reproductive medicine is branch of medicine that determine the male and female
reproductive system. It addresses about variety of reproductive system is assessment of better
treatment and progenies (Calogero and et. al., 2017). It allows have advances which overcame
with fertility as well as being a part to use in agriculture and wildlife conservation. The company
National Health Service, this public related sector company in healthcare service provider within
under government which is founded by National Health Service Act of 1946.
MAIN BODY
1. By using of Sperm from 'known donor' in an IVF cycle at National Health Service fertility
clinic in UK, who assumes parental responsibility of baby
In the case of Phillippa and Gareth, they both assumes parental responsibility of baby if it
was conceived as an embryo utilising eggs from women and sperm from known donor in the in
vitro fertilization cycle at National Health Services fertility clinic in United Kingdom. Under the
law of United Kingdom, if individuals undertaking treatment as a part of couple heterosexual
couple, then they both can be the legal parents of child. The human fertilisation and embryology
act of 2008 states that an unmarried man whose partner is having the donor sperm treatment will
be the father legally if the person and his partner consent to this in written form before the
conception. It also applies to the female couples who have similar sex and not in relationship
which has been legally formalised. In case of in case of Phillippa and Gareth, they both will have
the parental responsibility if it was conceived as an embryo using eggs and sperm in vitro
fertilization cycle National Health Services fertility clinic. It is the responsibility of the clinic to
make sure that the consent to legal parenthood forms should be completed before the treatment is
performed. In it, the boyfriend of Phillippa have the option to withdraw his consent to be a legal
parent of her child or Phillippa have the option to withdraw her consent to be the legal parent of
his child. However, it is only possible in case if they do this in writing prior to the treatment
initiates.
1

2. Explain Follicle stimulating hormone in context of Philippa pregnancy case.
As per the provided scenario, the periods of Phillippa are very sporadic and she knows
that her follicle stimulating hormone level is 59. The Follicle stimulating hormone is one of
essential hormone which is pubertal development and the function of ovaries system regulated in
woman bodies. The hormone stimulates the growth of ovaries is essential to pubertal
development and the function of women ovaries and men's testicle (Tang and et. al., 2020). The
production and release of follicle stimulating hormone is regulated by the level of number of
circulating hormones by ovaries and tests. In women hormone falls towards the end of menstrual
cycle where it worked through on cells in hypothalamus. Through the growth of follicle
stimulating hormone stimulus the growth of ovary system. In case of Phillippa, she is very upset
due to this as she assumed that occasional periods depicted fertility. At this time, the highest
priority of the couple, i.e., Phillippa and her husband Andrew is that to consult with the doctor in
order to get clear picture. Generally, in case of high follicle stimulating hormone levels (like
Phillippa), there may be chances of primary ovarian insufficiency which is the loss of ovarian
function before 40 years of age. Apart from this, she may have polycystic ovary syndrome which
is a common hormonal disorder that affects childbearing women. In addition to this, she may
have an ovarian tumour and Turner syndrome which is the genetic disorder that affects female's
sexual development and often causes infertility. Thus, to consult with the doctor must be the
highest priority at this time.
3. Discuss the treatment of frozen blastocysts. How would treatment continue if Philippa
continues towards amicable arrangement?
The frozen embryo transfer is at type of IVF treatment where is cryopreserved is
formulate creation of IVF cycle of thawed with transferred to a uterus. Philippa can easily
continue towards menstrual cycle which level naturally peak before ovulation. This is rise of
estrogen triggers that tend to beings producing progesterone (World Health Organization, 2018).
The treatment of Philippa continues towards born baby process with better arrangement by must
having better hospitality services of medical resources. The treatment can be counted on delaying
embryo transfer which involves in IVF cycles.
2

CONCLUSION
Through above report of Sexual and Reproductive medicine emphasis about as in case
where a girl name Philippa is facing pregnancy issue in her early age, where she has relationship
with her boyfriend. Now further situation is describing about the procedure which she has
follows to making her perfect pregnancy test. Through IVF cycle which explains about overall
treatment of ovaries and eggs of female reproductive system. The follicle hormone system which
explains about female control puberty system effectively. At last the treatment of Frozen
blastocysts which describes about in details for further treatment as in Philippa wants a friendly
treatment.
3

REFERENCES
Books and Journals
Calogero and et. al., 2017. The use of nutraceuticals in male sexual and reproductive
disturbances: position statement from the Italian Society of Andrology and Sexual
Medicine (SIAMS). Journal of endocrinological investigation. 40(12). pp.1389-1397.
Everett and et. al., 2019. Do sexual minorities receive appropriate sexual and reproductive health
care and counseling?. Journal of Women's Health. 28(1). pp.53-62.
Tang and et. al., 2020. Sexual and reproductive health (SRH): a key issue in the emergency
response to the coronavirus disease (COVID-19) outbreak. Reproductive Health. 17.
pp.1-3.
World Health Organization, 2018. WHO meeting on ethical, legal, human rights and social
accountability implications of self-care interventions for sexual and reproductive health,
12–14 March 2018, Brocher Foundation, Hermance, Switzerland: summary report (No.
WHO/FWC/18.30). World Health Organization.
4